SARS-CoV-2 triggers pericyte-mediated cerebral capillary constriction by Hirunpattarasilp, C, James, G, Kwanthongdee, J, Freitas, F, Huo, J, Sethi, H, Kittler, JT, Owens, RJ, McCoy, LE, Attwell, D

Broad and potent neutralization of HIV-1 by human-llama fusion antibodies derived from immunized llamas by McCoy LE, Rutten L, Dekkers G, Blanchetot C, Strokappe NM, Forsman-Quigley A, Seaman MS, de Haard H, Verrips T, Weiss RA

A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 determinant for neutralization but not for antigen recognition by Weissenhorn W, Lutje Hulsik D, Hock M, Liu YY, Strokappe NM, Khattabi ME, Langedijk JP, McCoy LE, Forsman-Quigley A, Aasa-Chapman MM, Weiss RA, Verrips TC, Rutten L

Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins by Schiffner, T, Pallesen, J, Russell, RA, Dodd, J, de Val, N, LaBranche, CC, Montefiori, D, Tomaras, GD, Shen, X, Harris, SL, Moghaddam, AE, Kalyuzhniy, O, Sanders, RW, McCoy, LE, Moore, JP, Ward, AB, Sattentau, QJ

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV by Alrubayyi, A, Gea-Mallorquí, E, Touizer, E, Hameiri-Bowen, D, Kopycinski, J, Charlton, B, Fisher-Pearson, N, Muir, L, Rosa, A, Roustan, C, Earl, C, Cherepanov, P, Pellegrino, P, Waters, L, Burns, F, Kinloch, S, Dong, T, Dorrell, L, Rowland-Jones, S, McCoy, LE, Peppa, D

SARS-CoV-2 evolution during treatment of chronic infection by Kemp, SA, Collier, DA, Datir, RP, Ferreira, IATM, Gayed, S, Jahun, A, Hosmillo, M, Rees-Spear, C, Mlcochova, P, Lumb, IU, Roberts, DJ, Chandra, A, Temperton, N, Sharrocks, K, Blane, E, Modis, Y, Leigh, KE, Briggs, JAG, van Gils, MJ, Smith, KGC, Bradley, JR, Smith, C, Doffinger, R, Ceron-Gutierrez, L, Barcenas-Morales, G, Pollock, DD, Goldstein, RA, Smielewska, A, Skittrall, JP, Gouliouris, T, Goodfellow, IG, Gkrania-Klotsas, E, Illingworth, CJR, McCoy, LE, Gupta, RK